Aptar Pharma MDI Add-on Device Aids in Patient Inhalation Technique, Adherence From: Aptar Pharma

ByLance T. Lee

Feb 18, 2022

The Aptar Pharma HeroTracker® The next-generation Sense metered-dose inhaler (MDI) transforms a standard metered-dose inhaler (pMDI) into a smart connected health device to help improve the lives of patients around the world suffering from chronic respiratory diseases, such as asthma , COPD, cystic fibrosis, and respiratory conditions caused by COVID-19, by tracking their use of metered-dose inhalers and facilitating better adherence to prescribed treatment.

By attaching to the cartridge of an MDI, HeroTracker® Sense has a number of features to help asthma and COPD patients take their medications in a more informed and compliant way. Device sensors enable the creation and delivery of information such as coordination of inspiration with actuation, rate and duration of inhalation. Other features available through the app include timestamps to indicate when the patient should take their medication, as well as environmental monitoring alerts, such as temperature and humidity.

hero tracker® Sense Empowers Healthcare Providers with Valuable Analytics and Insights into Patient Training, Onboarding and Performance with Aptar Pharma Cohero Health BreatheSmart® Connect Portal, which is both HIPAA and GDPR compliant, while patients can monitor their adherence through the BreatheSmart® application.

“Hero Tracker® Sense is a strategic addition to Aptar’s portfolio of digital health solutions in the respiratory space and underscores Aptar Pharma’s advancements in digital therapeutics, as well as our commitment to providing tools that will lead to improved patients’ lives,” said Sai Shankar, President, Digital Health, Aptar Pharma.

“The launch of HeroTracker® Sense is positioning Aptar’s Digital Respiratory Wallet as a world-leading offering, providing insights into patient behaviors and how this will drive change in how the patient interacts with their device and their understanding of their indication. We see this as a product for the future and one that will demonstrate significant value, creating concrete evidence that can help support reimbursement models in many different markets,” adds Marcus Bates, Director of Business Development, Digital Healthcare, Aptar Pharmaceuticals.

hero tracker® Sense was designed and developed using Aptar Digital Health’s ISO 13485 certified quality management system, is CE marked and is pending FDA approval.

Source link